# Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy

> **NCT00984802** · PHASE2 · COMPLETED · sponsor: **Ischemix, LLC** · enrollment: 142 (actual)

## Conditions studied

- Stable Coronary Artery Disease
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** CMX-2043
- **DRUG:** Placebo control

## Key facts

- **NCT ID:** NCT00984802
- **Lead sponsor:** Ischemix, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-04
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2011-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984802, "Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00984802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*